ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer

Descripción del Articulo

The ALK receptor tyrosine kinase (ALK) gene encodes a transmembrane protein rearranged in 2-7% of non-small cell lung cancer (NSCLC) cases. This gene has become the second most studied therapeutic target after EGFR due to the implied therapeutic opportunities. While the diagnostic of ALK rearrangeme...

Descripción completa

Detalles Bibliográficos
Autores: Rosas, G, Ruiz, Rossana, Araujo, JM, Pinto, JA, Mas L, Luis
Formato: artículo
Fecha de Publicación:2019
Institución:Instituto Nacional de Enfermedades Neoplásicas
Repositorio:INEN-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.inen.sld.pe:inen/131
Enlace del recurso:https://repositorio.inen.sld.pe/handle/inen/131
Nivel de acceso:acceso abierto
Materia:ALK
Diagnostic tests
Non-small cell lung cancer
Tyrosine-kinase inhibitors
https://purl.org/pe-repo/ocde/ford#3.02.21
id INEN_1fe6d3710cd93a2b7c7f8b5c0b2ab16e
oai_identifier_str oai:repositorio.inen.sld.pe:inen/131
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
spelling Rosas, GRuiz, RossanaAraujo, JMPinto, JAMas L, Luis2024-07-01T16:28:55Z2024-07-01T16:28:55Z2019The ALK receptor tyrosine kinase (ALK) gene encodes a transmembrane protein rearranged in 2-7% of non-small cell lung cancer (NSCLC) cases. This gene has become the second most studied therapeutic target after EGFR due to the implied therapeutic opportunities. While the diagnostic of ALK rearrangements is well established, small molecules targeting ALK are in constant evolution because tumor cells eventually will develop mechanisms of resistance. In this review we describe the biology of the ALK gene, alterations, epidemiology, diagnostic tests as well as strategies of treatment.application/pdf10.1016/j.critrevonc.2019.02.006https://repositorio.inen.sld.pe/handle/inen/131engCrit Rev Oncol HematolIEElsevier Ireland Ltdinfo:eu-repo/semantics/openAccessdc.rights.uri: https//creativecomons.org/licenses/by/4.0/ALKDiagnostic testsNon-small cell lung cancerTyrosine-kinase inhibitorshttps://purl.org/pe-repo/ocde/ford#3.02.21ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancerinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENPublicationORIGINALG Rosas 2019.pdfapplication/pdf322009https://repositorio.inen.sld.pe/bitstreams/4fa4ae8c-f6dc-476b-9479-b7f9548d12ac/download9601f485b7944d6f0c8ca349bd023199MD51TEXTG Rosas 2019.pdf.txtG Rosas 2019.pdf.txtExtracted texttext/plain52486https://repositorio.inen.sld.pe/bitstreams/512c29e5-c87b-40ba-95e9-82d56d1c301d/downloaded7f464a843e42cda0bd929454720d55MD52THUMBNAILG Rosas 2019.pdf.jpgG Rosas 2019.pdf.jpgGenerated Thumbnailimage/jpeg4046https://repositorio.inen.sld.pe/bitstreams/f9386d90-e6fe-4f7a-83fe-63828b6251b4/download151f0b88bd184b6bcf981fff4914517fMD53inen/131oai:repositorio.inen.sld.pe:inen/1312024-10-24 03:00:26.696dc.rights.uri: https//creativecomons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttps://repositorio.inen.sld.peRepositorio INENrepositorioinendspace@gmail.com
dc.title.none.fl_str_mv ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
title ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
spellingShingle ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
Rosas, G
ALK
Diagnostic tests
Non-small cell lung cancer
Tyrosine-kinase inhibitors
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
title_full ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
title_fullStr ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
title_full_unstemmed ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
title_sort ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
author Rosas, G
author_facet Rosas, G
Ruiz, Rossana
Araujo, JM
Pinto, JA
Mas L, Luis
author_role author
author2 Ruiz, Rossana
Araujo, JM
Pinto, JA
Mas L, Luis
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Rosas, G
Ruiz, Rossana
Araujo, JM
Pinto, JA
Mas L, Luis
dc.subject.none.fl_str_mv ALK
Diagnostic tests
Non-small cell lung cancer
Tyrosine-kinase inhibitors
topic ALK
Diagnostic tests
Non-small cell lung cancer
Tyrosine-kinase inhibitors
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description The ALK receptor tyrosine kinase (ALK) gene encodes a transmembrane protein rearranged in 2-7% of non-small cell lung cancer (NSCLC) cases. This gene has become the second most studied therapeutic target after EGFR due to the implied therapeutic opportunities. While the diagnostic of ALK rearrangements is well established, small molecules targeting ALK are in constant evolution because tumor cells eventually will develop mechanisms of resistance. In this review we describe the biology of the ALK gene, alterations, epidemiology, diagnostic tests as well as strategies of treatment.
publishDate 2019
dc.date.accessioned.none.fl_str_mv 2024-07-01T16:28:55Z
dc.date.available.none.fl_str_mv 2024-07-01T16:28:55Z
dc.date.issued.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.1016/j.critrevonc.2019.02.006
dc.identifier.uri.none.fl_str_mv https://repositorio.inen.sld.pe/handle/inen/131
identifier_str_mv 10.1016/j.critrevonc.2019.02.006
url https://repositorio.inen.sld.pe/handle/inen/131
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Elsevier Ireland Ltd
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv dc.rights.uri: https//creativecomons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv dc.rights.uri: https//creativecomons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Crit Rev Oncol Hematol
dc.publisher.country.none.fl_str_mv IE
publisher.none.fl_str_mv Crit Rev Oncol Hematol
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
bitstream.url.fl_str_mv https://repositorio.inen.sld.pe/bitstreams/4fa4ae8c-f6dc-476b-9479-b7f9548d12ac/download
https://repositorio.inen.sld.pe/bitstreams/512c29e5-c87b-40ba-95e9-82d56d1c301d/download
https://repositorio.inen.sld.pe/bitstreams/f9386d90-e6fe-4f7a-83fe-63828b6251b4/download
bitstream.checksum.fl_str_mv 9601f485b7944d6f0c8ca349bd023199
ed7f464a843e42cda0bd929454720d55
151f0b88bd184b6bcf981fff4914517f
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio INEN
repository.mail.fl_str_mv repositorioinendspace@gmail.com
_version_ 1843705566728290304
score 12.791002
ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares